Correction to: Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non‑Asian Patients with Atrial Fibrillation: A Systematic Review and Meta‑Analysis

Carlos Escobar; Vivencio Barrios; Professor Gregory Lip; Alpesh Amin; Ariadna Auladell-Rispau; Marilina Santero; Josefina Salazar; Carolina Requeijo

doi:10.1007/s40261-022-01126-w

Article2021

Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis

Carlos Escobar, Vivencio Barrios, Professor Gregory Lip, Alpesh Amin, Ariadna Auladell-Rispau, Marilina Santero, Josefina Salazar, Carolina Requeijo

Article2021

Effectiveness and safety of dabigatran compared to vitamin K antagonists in patients with atrial fibrillation: a systematic review and metanalysis.

Carlos Escobar, Vivencio Barrios, Professor Gregory Lip, Alpesh Amin, Ariadna Auladell-Rispau, Carolina Requeijo

Letter2019

Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review

Steve Deitelzweig, Professor Gregory Lip

Article2017

Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation

Myung‐Jin Cha, Eue-Keun Choi, Kyungdo Han, So-Ryoung Lee, Woo‐Hyun Lim, Seil Oh, Professor Gregory Lip

Corrigendum2022

Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry

Professor Gregory Lip, Agnieszka Kotalczyk, Christine Teutsch, Hans-Christoph Diener, Sérgio Dubner, Jonathan L. Halperin, Changsheng Ma, Kenneth J. Rothman, Sabrina Marler, Venkatesh Kumar Gurusamy, Menno V. Huisman, Dzifa Wosornu Abban, Emad F. Aziz, Marica Bracic Kalan, Nasser Abdul, Luciano Marcelo Backes, Drew Bradman, Atilio Marcelo Abud, E. Badings, D. H. Brautigam, Fran Adams, Ermentina Bagni,

Correction to: Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non‑Asian Patients with Atrial Fibrillation: A Systematic Review and Meta‑Analysis

Discussion(0)

Related publications

Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis

Effectiveness and safety of dabigatran compared to vitamin K antagonists in patients with atrial fibrillation: a systematic review and metanalysis.

Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review

Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation

Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry